Bosentan-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome

Journal of Rheumatology

Volumn 37, Issue 5, 2010, Pages 1077-1078

  Allanore, Yannick ^a   Moachon, Laurence ^b   Maury, Emilie ^b   Isvy, Anne ^b   Kahan, André ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; BOSENTAN; COTRIMOXAZOLE; DNA TOPOISOMERASE; DOMPERIDONE; HYDROXYZINE; ILOPROST; NICARDIPINE; OMEPRAZOLE; PENICILLIN G; PREDNISONE; WARFARIN; ZOLPIDEM;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; BILIARY TRACT DISEASE; BLOOD ANALYSIS; CASE REPORT; CLINICAL EXAMINATION; DRESS SYNDROME; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ECHOGRAPHY; EOSINOPHIL COUNT; FEMALE; FEVER; FINGER MALFORMATION; HEADACHE; HEPATITIS; HUMAN; HYPERSENSITIVITY REACTION; LETTER; LUNG FIBROSIS; MACULOPAPULAR RASH; PRIORITY JOURNAL; RECURRENT DISEASE; SYSTEMIC SCLEROSIS; TREATMENT DURATION;

AGED; ANTI-ULCER AGENTS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; EXANTHEMA; FEMALE; FEVER; HUMANS; SCLERODERMA, SYSTEMIC; SULFONAMIDES; SYNDROME;

EID: 77951828971     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.091266     Document Type: Letter

References (10)

1. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007;156:609-611
2. Mardivirin L, Valeyrie-Allanore L, Branlant-Redon E, Beneton N, Jidar K, Barbaud A, et al. Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on human herpesvirus 6 replication in vitro. Eur J Dermatol 2010;20:68-73.
3. Ben m'rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, et al. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine 2009;88:131-140
4. Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol 2009;145:67-72.
5. Humbert M, Segal ES, Kiely DG, Carlsen J, Schwierin B, Hoeper MM. Results of European postmarketing surveillance of bosentan in pulmonary hypertension. Eur Respir J 2007;30:338-344 (Pubitemid 47194187)
6. Nagai Y, Yamanaka M, Nishimura S, Nakano A, Hasegawa A, Ishikawa O. Drug eruption due to bosentan in a patient with systemic sclerosis. Mod Rheumatol 2006;16:188-190 (Pubitemid 43871697)
7. Romano A, Giovannetti A, Caruso C, Rosato E, Pierdominici M, Salsano F. Delayed hypersensitivity to bosentan. Allergy 2009;64:499-501.
8. Actelion Ltd. Summary of bosentan product characteristics. January 2010. [Internet. Accessed February 11, 2010.] Available from: http://www1.actelion. com/documents/corporate/smpc-pils/ Tracleer-SmPC.pdf
9. Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 2003;349:1628-1635 (Pubitemid 37288569)
10. Brackett CC. Sulfonamide allergy and cross-reactivity. Curr Allergy Asthma Rep 2007;7:41-48